TC
VTVT icon

Truvestments Capital’s vTv Therapeutics VTVT Stock Holding History

Truvestments Capital’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.38K Buy
+143
New +$4.96K ﹤0.01% 888

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Truvestments Capital's VTVT Position: Q2 2026 in Review

Truvestments Capital opened a new position in vTv Therapeutics (VTVT) in Q2 2026: 143 shares worth $5.38K. The stake represents ﹤0.01% of the portfolio and ranks #888 among its holdings.

45 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Truvestments Capital held 143 shares of vTv Therapeutics worth $5.38K as of Q2 2026.
  • vTv Therapeutics was a new Truvestments Capital position in Q2 2026.
  • vTv Therapeutics made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #888 holding.
  • 45 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.